share_log

PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.

PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.

PainReform股票交易下跌。該公司宣佈了關於其針對接受蹠骨切除術患者術後疼痛管理的PRF-110三期臨牀試驗的最新進展。
Benzinga ·  2024/12/28 01:43

PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.

PainReform股票交易下跌。該公司宣佈了關於其針對接受蹠骨切除術患者術後疼痛管理的PRF-110三期臨牀試驗的最新進展。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論